Literature DB >> 26763130

Fructose and glucose combined with free fatty acids induce metabolic disorders in HepG2 cell: A new model to study the impacts of high-fructose/sucrose and high-fat diets in vitro.

Liang Zhao1, Xiaoxuan Guo1, Ou Wang1, Hongjuan Zhang2, Yong Wang1, Feng Zhou1, Jia Liu3, Baoping Ji1.   

Abstract

SCOPE: This work investigated the underlying mechanism of high-fructose/sucrose and high-fat diets, which rapidly induce metabolic syndrome in vivo, via a new cell model. METHODS AND
RESULTS: Glucose and/or fructose were used to induce the human hepatoma cell (HepG2) in the presence of palmitic acid, oleic acid, or combined fatty acids (CFA) for 24 h. The alterations in lipid and uric acid production, glucose metabolism, oxidative status, and related genes and proteins were monitored. The cell model that featured metabolic disorders was established by treatment of 10 mM glucose and 15 mM fructose plus 1 mM CFA. Results showed that palmitic acid mainly induced insulin resistance, oxidative stress, and triglyceride (TG) secretion, whereas oleic acid mainly contributed to intracellular TG. Fructose was mainly responsible for uric acid and cholesterol production. In addition, fructose synergistically elevated the intra- and extracellular TG and extracellular malonaldehyde with glucose and CFA. Regulations of genes and proteins associated with carbohydrate metabolism and lipogenesis partially explained the action of fructose in inducing the metabolic disorders in cell.
CONCLUSION: The combination of glucose, fructose, and CFA could successfully induce metabolic disorders in HepG2 cells, including dyslipidemia, insulin resistance, hyperuricemia, and oxidative stress.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cell model; Free fatty acids; Fructose; HepG2; Metabolic disorders

Mesh:

Substances:

Year:  2016        PMID: 26763130     DOI: 10.1002/mnfr.201500635

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  17 in total

1.  High fructose causes cardiac hypertrophy via mitochondrial signaling pathway.

Authors:  Yan-Bo Zhang; Yan-Hai Meng; Shuo Chang; Rong-Yuan Zhang; Chen Shi
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

2.  Dietary Ferulic Acid Ameliorates Metabolism Syndrome-Associated Hyperuricemia in Rats via Regulating Uric Acid Synthesis, Glycolipid Metabolism, and Hepatic Injury.

Authors:  Nanhai Zhang; Jingxuan Zhou; Lei Zhao; Ou Wang; Liebing Zhang; Feng Zhou
Journal:  Front Nutr       Date:  2022-06-30

3.  Differential capability of metabolic substrates to promote hepatocellular lipid accumulation.

Authors:  Ngoc Anh Hoang; Friederike Richter; Martin Schubert; Stefan Lorkowski; Lars-Oliver Klotz; Holger Steinbrenner
Journal:  Eur J Nutr       Date:  2018-10-27       Impact factor: 5.614

4.  Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.

Authors:  Anil Bhatta; Lin Yao; Zhimin Xu; Haroldo A Toque; Jijun Chen; Reem T Atawia; Abdelrahman Y Fouda; Zsolt Bagi; Rudolf Lucas; Ruth B Caldwell; Robert W Caldwell
Journal:  Cardiovasc Res       Date:  2017-11-01       Impact factor: 10.787

5.  Systemic and vascular inflammation in an in-vitro model of central obesity.

Authors:  Arti Ahluwalia; Alessandra Misto; Federico Vozzi; Chiara Magliaro; Giorgio Mattei; Maria Cristina Marescotti; Angelo Avogaro; Elisabetta Iori
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

6.  High Glucose Induces Lipid Accumulation via 25-Hydroxycholesterol DNA-CpG Methylation.

Authors:  Yaping Wang; Lanming Chen; William M Pandak; Douglas Heuman; Phillip B Hylemon; Shunlin Ren
Journal:  iScience       Date:  2020-04-29

7.  Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease.

Authors:  Elaina M Maldonado; Ciarán P Fisher; Dawn J Mazzatti; Amy L Barber; Marcus J Tindall; Nicholas J Plant; Andrzej M Kierzek; J Bernadette Moore
Journal:  NPJ Syst Biol Appl       Date:  2018-08-20

8.  Augmentation of Glucotoxicity, Oxidative Stress, Apoptosis and Mitochondrial Dysfunction in HepG2 Cells by Palmitic Acid.

Authors:  Arwa Alnahdi; Annie John; Haider Raza
Journal:  Nutrients       Date:  2019-08-22       Impact factor: 5.717

9.  Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis.

Authors:  Pippa J Gunn; Camilla Pramfalk; Val Millar; Thomas Cornfield; Matthew Hutchinson; Elspeth M Johnson; Shilpa R Nagarajan; Perla Troncoso-Rey; Richard F Mithen; Katherine E Pinnick; Maria H Traka; Charlotte J Green; Leanne Hodson
Journal:  Physiol Rep       Date:  2020-07

Review 10.  An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.

Authors:  Priscila Silva Figueiredo; Aline Carla Inada; Melina Ribeiro Fernandes; Daniela Granja Arakaki; Karine de Cássia Freitas; Rita de Cássia Avellaneda Guimarães; Valter Aragão do Nascimento; Priscila Aiko Hiane
Journal:  Molecules       Date:  2018-04-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.